Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt.
National Haemoglobinopathy Reference Laboratory, Oxford Radcliffe Hospitals National Health Service Trust, Oxford, UK.
Hemoglobin. 2020 May;44(3):195-200. doi: 10.1080/03630269.2020.1783288. Epub 2020 Jun 29.
Over many years, cases of suspected α-globin chain variants were collected from different parts of the UK. The suspicion was based on the clinical picture, high performance liquid chromatography (HPLC) variant percentage, retention time (RT) and isoelectric focusing (IEF). DNA sequencing and the restriction enzyme EI were used for definitive diagnosis. One hundred and forty-eight variants were confirmed on one or both of the two α-globin genes (, ). These cases were identified as 46 different α-globin chain variants. The most common variants were Hb J-Meerut [: c.362C>A (or )] (10.1%) and Hb Q-India (: c.193G>C) (8.1%), followed by Hb J-Paris-I [: c.38C>A (or )] and Hb Manitoba II (: c.309C>A) (7.4% for each). Other α variants were detected at lower frequencies. Two novel alleles were also detected: Hb Walsgrave [α116(GH4)Glu→Val (: c.350A>T)] and Hb Coombe Park [α127(H10)Lys→Glu (: c.382A>G)]. The majority of the ethnic origin was Indian. The positive predictive value for α variant identification by HPLC-RT analysis was 65.9%, 41.9% by IEF, and using both RT and IEF, the value was 72.1%. The number of variants was higher in than in genes and in exons 1 and 2 than in exon 3. There was no clustering of mutations in consecutive codons. This study, the characterization of a wide spectrum of α-globin chain variants, can facilitate the presumptive diagnosis of these variants prior to screening by a panel of amplification refractory mutation system-polymerase chain reaction (ARMS-PCR), and a definitive diagnosis by DNA sequencing.
多年来,英国各地收集了疑似α-珠蛋白链变异的病例。怀疑是基于临床表现、高效液相色谱(HPLC)变异百分比、保留时间(RT)和等电聚焦(IEF)。DNA 测序和限制酶 EI 用于明确诊断。在两个α-珠蛋白基因(,)中的一个或两个上证实了 148 种变体。这些病例被确定为 46 种不同的α-珠蛋白链变体。最常见的变体是 Hb J-Meerut [:c.362C>A(或)](10.1%)和 Hb Q-India [:c.193G>C](8.1%),其次是 Hb J-Paris-I [:c.38C>A(或)]和 Hb Manitoba II [:c.309C>A](每种 7.4%)。其他α变体的检出频率较低。还检测到两种新的等位基因:Hb Walsgrave [α116(GH4)Glu→Val [:c.350A>T]]和 Hb Coombe Park [α127(H10)Lys→Glu [:c.382A>G]]。大多数种族起源于印度。通过 HPLC-RT 分析鉴定α变异的阳性预测值为 65.9%,IEF 为 41.9%,使用 RT 和 IEF 的值为 72.1%。在 1 号基因和 2 号外显子中,变体的数量高于 3 号外显子,在 1 号和 2 号外显子中,变体的数量高于 3 号外显子。连续密码子中没有突变簇。这项研究对广泛的α-珠蛋白链变体进行了特征描述,可在通过扩增抗性突变系统-聚合酶链反应(ARMS-PCR)进行小组筛选之前,有助于对这些变体进行推测性诊断,并通过 DNA 测序进行明确诊断。